🇺🇸

US SEC Filing Intelligence

· daily

S&P 500 Technology Sector SEC Filings — May 19, 2026

The 12 filings reveal a bifurcated S&P 500 Technology landscape: established hardware leaders like Cisco are delivering strong revenue growth (12% YoY) and margin expansion, while smaller, speculative tech and biotech names show mixed signals—ranging from a major equity turnaround at AIM ImmunoTech to a widening loss at Bravo Multinational. A clear thematic driver is the AI infrastructure buildout, evidenced by Blockchain Digital Infrastructure's tripling operating cash flow and Analog Devices' strategic acquisition of Empower Semiconductor. Insider activity is sparse but notable for the lack of selling, while capital allocation trends point to reinvestment (M&A) over shareholder returns. Forward-looking catalysts are concentrated in biotech (Immunic's Phase 3 readout) and AI data center development (Blockchain Digital's 395 MW pipeline). The most actionable insights center on Cisco's operational efficiency, Immunic's upcoming trial catalyst, and the sector-wide push into power management and AI compute capacity.

4 high priority 8 medium 12 total filings
· daily

Nasdaq 100 Stocks SEC Filings — May 19, 2026

The May 19, 2026 filing batch for the NASDAQ-100 stream reveals a bifurcated market with strong operational performance at scale (Cisco) contrasting with micro-cap distress (Bravo Multinational, AIM ImmunoTech). The dominant theme is strategic portfolio repositioning: Cisco delivered a standout 12% YoY revenue beat with 35% net income growth, while Analog Devices and Maui Land & Pineapple are pursuing transformative M&A/asset sales. The XAI Madison Equity Premium Income Fund is executing a strategic sub-adviser addition to diversify its income strategy, signaling a shift toward preferred equity. However, the small-cap names show acute financial strain—Bravo Multinational's net loss widened 82% YoY, and AIM ImmunoTech only recently climbed out of a negative equity position. Insider activity is notably absent across the large-cap filers, while capital allocation actions (Kennametal's debt tender, PayPal's equity plan) suggest a focus on balance sheet management. The forward-looking catalyst calendar is anchored by Immunic's Phase 3 MS trial readout (YE 2026) and ADI's Empower Semiconductor deal closing (H2 2026), offering event-driven opportunities. Overall, the data signals a 'flight to quality' within the NASDAQ-100, where scale, cash flow, and strategic clarity are rewarded, while smaller names face existential refinancing risks.

5 high priority 7 medium 12 total filings
· daily

S&P 500 Financials Sector SEC Filings — May 19, 2026

The 50 filings for the S&P 500 Financials sector on May 19, 2026, reveal a sector bifurcated between strong revenue growth and significant margin compression. While top-line growth is evident across several sub-sectors (e.g., Energy Vault's 156% YoY revenue surge, Eagle Materials' record $2.3B revenue), profitability is under severe pressure, with net earnings declining at major firms like Home Depot (-4.2% YoY) and Eagle Materials (-9% YoY). The most critical developments include a wave of SPAC activity and business combinations (Plum Acquisition, SoftVest, Bleichroeder), signaling a potential consolidation phase, alongside notable insider actions like GitLab's chair converting all super-voting shares, which reduces governance risk. Capital allocation trends show a mix of aggressive buybacks (News Corp's $1B program) and strategic debt financing (Granite Construction's $600M notes), indicating a focus on shareholder returns and growth investment. A key portfolio-level pattern is the 'growth at all costs' theme, where companies like Thermon Group and Energy Vault are sacrificing near-term GAAP profitability for long-term market share and strategic positioning, a trend that demands careful scrutiny of cash burn rates and debt levels.

21 high priority 29 medium 50 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — May 19, 2026

The 50 filings from the S&P 500 Consumer Staples sector reveal a sector under significant pressure, with mixed results across the board. While top-line growth is evident in some areas (Novelis +7.5% YoY, Thermon +11% YoY), profitability is being squeezed by rising costs, operational disruptions, and strategic investments. A key theme is the divergence between operational metrics and financial results, as seen in Under Armour's widening net loss (-$495.6M) despite cost-cutting, and Educational Development Corp's profit turnaround driven by a one-time asset sale. Insider activity is limited, but capital allocation is active, with major debt offerings (Pinnacle Financial $750M, Blackstone Mortgage $450M) and a significant share repurchase (HF Sinclair $100M). The most critical developments include the pending $2.2B Thermon/CECO merger, Paramount Skysdance's $51.9B acquisition financing plan for Warner Bros. Discovery, and Novelis's operational recovery from the Oswego plant fires. Portfolio-level patterns point to a sector grappling with inflation, supply chain issues, and the need for strategic transformation, creating a landscape of both significant risks and selective opportunities for investors.

18 high priority 32 medium 50 total filings
· daily

S&P 500 Industrials Sector SEC Filings — May 19, 2026

The 50 filings reveal a mixed landscape for S&P 500 Industrials, with several companies showing revenue declines and margin compression, while others exhibit strong turnaround stories or strategic moves. Notable period-over-period trends include revenue drops at Red Robin (-3.6% YoY), Educational Development Corp (-33% YoY), and SunPower (-7.2% YoY), contrasted with Home Depot's 4.8% YoY sales growth. Insider activity is limited, but significant capital allocation actions include FB Bancorp's 10% share buyback and Blackstone Mortgage Trust's $450M debt issuance. Forward-looking statements highlight Einride's SPAC merger (June 4 vote) and Iridex's positive cash flow guidance. The most critical developments are Bitcoin Depot's Nasdaq delisting due to bankruptcy, CNS Pharmaceuticals' dilutive S-3 filing, and Oramed's swing to profitability on non-operating income. Portfolio-level themes include margin pressure in consumer-facing industrials, increased leverage in real estate, and a shift toward AI and quantum computing investments.

20 high priority 30 medium 50 total filings
· daily

S&P 500 Energy Sector SEC Filings — May 19, 2026

The four S&P 500 Energy filings reveal a sector dominated by routine corporate governance events—annual meetings and shareholder votes—with limited operational or strategic surprises. However, enriched data uncovers critical undercurrents: Baker Hughes faces notable shareholder dissent on compensation (7.2% against say-on-pay) and director elections, signaling governance friction despite overall approval. Ultrapar Holdings presents a mixed financial picture with top-line revenue growth of 6.6% YoY but declining gross profit (-3.4% YoY), rising debt (+44.6% YoY), and a loss from discontinued operations, pointing to operational strain and balance sheet risk. Kinder Morgan and SunCoke Energy show strong shareholder support with minimal dissent, reflecting stable governance. The key portfolio-level pattern is a divergence between governance stability (KMI, SUN) and emerging governance/operational risks (BKR, UGP), suggesting selective investor caution. No forward-looking guidance, insider trading, or capital allocation changes were reported, limiting actionable catalysts but highlighting the need to monitor Ultrapar's debt trajectory and Baker Hughes' compensation dynamics.

1 high priority 3 medium 4 total filings
· daily

US Material Events SEC 8-K Filings — May 19, 2026

The May 19, 2026, filing batch reveals a market dominated by capital structure maneuvers, with a clear bifurcation between companies aggressively refinancing or raising debt (Blackstone Mortgage Trust, Sabre Corp, Humana, Southwest Airlines) and those executing strategic M&A or asset sales (Permian Resources, Bank First Corp, GoPro). Insider activity is largely absent from these filings, shifting focus to capital allocation signals: share buybacks (HF Sinclair) and debt-for-equity swaps (Jaguar Health) indicate varied financial health. A significant undercurrent is the wave of shareholder dissent on compensation plans, with several companies (DHI Group, ACCO Brands, Permian Resources) seeing notable 'against' votes, signaling potential governance friction. Forward-looking data points to key catalysts in H2 2026, including Phase 3 readouts for Immunic and pivotal trial enrollment for Nexalin. Overall, the digest points to a market where liquidity management and strategic pivots are paramount, with governance issues emerging as a key risk factor.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — May 19, 2026

The May 19, 2026 filing batch for the Dow 30 stream reveals a market bifurcated between resilient consumer-facing giants and deeply distressed smaller entities. The dominant theme is margin compression, with Home Depot reporting a 100 bps operating margin decline despite 4.8% revenue growth, while CAVA Group's 32.2% revenue surge was overshadowed by a net income drop. A significant M&A wave is cresting, with the $2.2B Publicis/LiveRamp deal and Thermon/CECO merger creating actionable catalysts, though Two Harbors' adjourned shareholder vote signals deal execution risk. The most alarming trend is the cash burn across the portfolio: Energy Vault's cash used in operations surged 20x to $53.8M, Sono Group posted negative equity, and Ehave's losses widened 31.6% with only $2,183 in revenue. Insider activity is sparse but telling, with no major insider buying detected, while the restatement at Driven Brands ($77M cumulative EBITDA hit) and the PFIC warning from 36Kr represent significant governance and tax risks. The opportunity set lies in the M&A arbitrage (LiveRamp at $38.50/sh) and the turnaround plays at Novelis (Oswego restart) and CAVA (raised guidance), but the overall tone is cautious, favoring quality and liquidity.

11 high priority 39 medium 50 total filings
· daily

US SEC Filings Daily Market Digest — May 19, 2026

Today's digest reveals a market bifurcated between robust operational growth in select industrials and energy transition plays, and deepening financial distress in several small-cap and micro-cap names. Key themes include a flurry of SPAC activity with both high-profile deals (Einride, Pasqal) and deadline extensions (Plum IV) signaling execution risk, while capital-intensive sectors like cement and data centers show strong volume growth but margin compression. Notable distress signals emerge from Natural Alternatives, Ehave, and TechPrecision, where cash burn, covenant pressure, and related-party financing are acute. Insider activity is limited but notable: GitLab's chair converted all super-voting shares for tax planning, while Home Depot's reaffirmed guidance provides a steady anchor. The day is rich with forward-looking catalysts, including upcoming shareholder votes for the Thermon/CECO merger and Einride's de-SPAC, and a slate of IPOs from foreign issuers with governance risks. Overall, the data suggests a 'barbell' market where high-quality growth and distressed assets coexist, demanding selective positioning.

22 high priority 28 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — May 19, 2026

The 50 filings for the S&P 500 Consumer Discretionary stream on May 19, 2026, reveal a sector bifurcated between strong top-line growth and margin compression. Home Depot's Q1 results exemplify this, with sales up 4.8% YoY but net earnings down 4.2% and operating margins contracting 100 bps, leading to a reaffirmed but cautious full-year guidance. The most significant capital allocation signal comes from HF Sinclair Corp, which executed its 21st share repurchase from a single holder, totaling $717M of a $1B program, indicating a strong commitment to returning capital. M&A activity is concentrated in the financial and energy sectors, with Bank First Corp's $202.9M all-stock acquisition of PSB Holdings and the proposed business combination for Permian Basin Royalty Trust, both carrying execution risk. Insider activity is notably absent across consumer discretionary names, but several SPACs (FortuneX, FG Merger III) are actively seeking targets, creating a pipeline of potential future transactions. The most critical risk is the accounting restatement at BestGofer Inc., which revealed a $78,754 goodwill impairment and a 12x increase in net loss, a severe red flag for micro-cap governance. Overall, the sector shows resilience in demand but faces profitability headwinds, with investors favoring companies that demonstrate clear capital return policies and operational efficiency.

15 high priority 35 medium 50 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — May 19, 2026

The 42 filings for the S&P 500 Healthcare sector reveal a sector in transition, with significant capital market activity (IPOs, SPACs, debt offerings) and strategic repositioning (M&A, name changes, C-suite transitions) overshadowing operational results. Key period-over-period trends from the limited operational data available show a stark divergence: Cisco's 12% revenue growth and 35% net income surge contrast sharply with BioForce Nanosciences' continued revenue-less losses and Parabilis Medicines' widening net losses of $145.9M. The most critical developments include Parabilis Medicines' IPO filing with a concurrent $75M Regeneron private placement, signaling strong strategic interest in its pipeline, and Humana's $1.5B P-Caps issuance, a complex capital management move. Insider activity is notably absent across the healthcare filings, but the high volume of capital allocation events (debt offerings, buybacks, IPO filings) suggests a sector actively managing its balance sheet and growth trajectory. Portfolio-level patterns indicate a focus on liquidity management (TechPrecision's credit extension, Humana's P-Caps) and a cautious but present appetite for growth capital (Parabilis IPO, Energy Transition SPAC IPO).

13 high priority 29 medium 42 total filings
· daily

US Executive Compensation Proxy SEC Filings — May 19, 2026

The three proxy filings reveal a period of corporate governance evolution and strategic realignment, with a notable absence of aggressive executive compensation changes. The dominant theme is the restructuring of advisory relationships, as seen in RBB Fund's proposal to add a co-adviser, which is a non-financial event for shareholders but signals operational consolidation in the asset management space. iAnthus Capital's filing is a routine governance exercise post-recapitalization, with no new compensation data, while MongoDB's proxy focuses on governance modernization (eliminating supermajority voting) and standard director elections, with no disclosed changes to executive pay. Across all three, there is a lack of period-over-period compensation trends, insider trading activity, or forward-looking financial guidance, limiting the depth of quantitative signals. The most actionable insights stem from the scheduled shareholder meetings and governance proposals, which provide near-term catalysts for monitoring shareholder sentiment and potential activist involvement. The overall sentiment is neutral, with materiality ranging from low (MongoDB) to moderate (RBB Fund), reflecting the routine nature of these filings.

3 high priority 3 total filings
· daily

US IPO Pipeline SEC S-1 Filings — May 19, 2026

The IPO pipeline on May 19, 2026, presents a highly polarized landscape, ranging from a development-stage interior design company with a going concern warning to a biotech firm with a $75M strategic investment from Regeneron. The most significant period-over-period trend is the escalating cash burn at Parabilis Medicines, where net losses widened 24% YoY to $145.9M, contrasting sharply with the nascent stage of Lawaken Group, whose CEO compensation surged 531% YoY to $1.85M despite a lack of employee benefits. A notable capital allocation pattern emerges with JAB Acquisition Corp I raising $150M in a SPAC IPO, signaling continued appetite for blank-check vehicles targeting tech, healthcare, and logistics. The absence of insider trading data across all filings is a critical gap, limiting conviction signals. The most actionable development is Regeneron's $75M private placement in Parabilis at a 10% discount to the IPO price, which provides a strong validation signal but also creates a potential overhang. The pipeline is dominated by high-risk, early-stage issuers, with 3 of 5 filings showing negative or going-concern sentiment, suggesting a cautious market reception ahead.

5 high priority 5 total filings
· daily

Global High-Priority Regulatory Events — May 19, 2026

The 50 filings from May 19, 2026, reveal a market dominated by capital return events (buybacks/dividends) and significant M&A/de-SPAC activity, but with underlying financial stress in several sectors. A clear theme is the aggressive return of capital to shareholders, with Dhanuka Agritech, Zydus Lifesciences, Welspun Living, and Sarla Performance Fibers announcing buybacks totaling over ₹1,466 crore, signaling strong balance sheets and management confidence. However, this is contrasted by severe financial distress in the US small-cap space, where Natural Alternatives International (NAII) reported a 79% gross profit collapse and TechPrecision Corp secured only a 4-month credit extension, highlighting acute liquidity pressures. The M&A landscape is active but mixed; the Einride/Legato de-SPAC is progressing with a $1.35B valuation and a June 4 vote, while the Permian Basin Royalty Trust deal remains non-binding and the Plum/Controlled Thermal merger faces delays. Insider activity is sparse but notable, with a significant 2.9M share sale by Invesco in Delhivery and a promoter pledge exceeding 50% at Damodar Industries, both bearish signals. Overall, the digest points to a bifurcated market: cash-rich companies are rewarding shareholders, while others face existential refinancing risks and operational deterioration.

50 high priority 50 total filings
· daily

US Earnings Financial Results SEC Filings — May 19, 2026

The 36 filings from May 19, 2026, reveal a bifurcated market where top-line growth is often masking underlying margin compression and cash flow deterioration. A clear theme is 'growth at a cost,' with companies like Cisco (12% revenue growth) and Energy Vault (156% revenue growth) showing strong sales but facing margin pressure or widening losses. Conversely, several micro-cap and pre-revenue companies (e.g., ShorePower, RMX Industries) are experiencing severe revenue declines and cash burn, signaling distress. Insider activity is notably absent from the filings, limiting conviction signals, but capital allocation patterns show a mix of aggressive reinvestment (Eagle Materials, Movano) and debt-fueled growth (Nextpower, James Hardie). The most actionable intelligence lies in identifying companies with genuine operational leverage versus those masking structural issues with one-time gains or accounting adjustments. Key sectors to watch include energy storage (Energy Vault's explosive growth vs. cash burn) and building materials (James Hardie's AZEK integration vs. Eagle Materials' margin resilience).

36 high priority 36 total filings
· daily

US SEC Trading Suspension Halt Orders — May 19, 2026

The single filing for May 19, 2026, from Bitcoin Depot Inc. (BTM) represents a catastrophic corporate event: a Chapter 11 bankruptcy filing immediately triggering a Nasdaq delisting. This is the highest materiality event possible (10/10), with the company not appealing the delisting, effectively confirming a total equity wipeout for common shareholders. The delisting is driven by both the bankruptcy (Nasdaq Rules 5101, 5110(b), IM-5101-1) and a failure to file a timely Form 10-Q (Rule 5250(c)), indicating severe operational and reporting distress. The company's own filing explicitly warns of a 'significant or complete loss' for security holders. With only one filing in the stream, the dominant theme is a single-entity, high-severity credit and equity risk event with no mitigating factors or positive trends.

1 high priority 1 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — May 19, 2026

The 40 filings from May 19, 2026, paint a picture of a market bifurcated between aggressive capital management and acute distress. While several firms (STORE Capital, Diversified Energy, Kimbell Royalty) are successfully refinancing debt at lower rates or making accretive acquisitions, a significant cluster of companies is exhibiting classic pre-bankruptcy distress signals. Bitcoin Depot has already filed for Chapter 11 and faces delisting, while TechPrecision, Zoomcar, and Aether Holdings are executing last-resort financing or settlement agreements that signal severe liquidity constraints. The period-over-period data reveals a troubling trend: revenue growth is anemic or negative for many, with net losses widening dramatically (MSP Recovery's loss doubled to $457.8M, Eagle Materials' earnings fell 9% despite record revenue). A wave of dilutive equity offerings (GeoVax, Rapid Micro, Sunshine Biopharma) and distressed debt exchanges (Jaguar Health, InMed) suggests a 'cash-for-equity' cycle is accelerating among micro-cap and clinical-stage biotechs. The most actionable insight is the stark contrast between well-capitalized firms using favorable debt markets to lock in low rates and distressed entities burning through their last options, creating a clear 'haves vs. have-nots' dynamic in the current credit environment.

40 high priority 40 total filings
· daily

US Executive Officer Management Changes SEC — May 19, 2026

This batch of 48 filings reveals a significant wave of leadership transitions across US equities, with notable CEO and CFO appointments at Rogers Corporation, Amerant Bancorp, and A. O. Smith, alongside the unexpected death of TOMI Environmental Solutions' CFO. A key theme is the high level of shareholder dissent on executive compensation, with Skyworks Solutions failing its say-on-pay vote (50.1% against) and several other companies (NOVAGOLD, Permian Resources, ACCO Brands) seeing over 20% opposition. Insider activity is limited to compensation-driven grants, but the lack of open-market purchases suggests caution. Forward-looking catalysts include Immunic's Phase 3 ENSURE trial readout by end of 2026 and Vistagen's new CMO appointment. Capital allocation trends show a focus on equity plan expansions (e.g., Roper Technologies adding 14.15M shares) rather than buybacks or dividends, signaling a bias toward employee retention. The most material event is the Skyworks say-on-pay failure, which could trigger board-level compensation reviews and potential activist interest.

48 high priority 48 total filings
· daily

US Corporate Board Director Changes SEC Filings — May 19, 2026

The 48 filings reveal a heavy focus on annual meeting outcomes and board composition changes, with several high-profile director appointments and executive transitions. Notable trends include significant shareholder dissent on executive compensation and equity plan amendments at multiple companies (e.g., ACCO Brands, Skyworks Solutions, NOVAGOLD), indicating growing investor scrutiny. Several companies appointed new CFOs or CEOs (e.g., A. O. Smith, Rogers Corp, Amerant Bancorp), signaling strategic leadership shifts. The unexpected death of TOMI Environmental's CFO and the resignation of Upstart's board member Jeff Huber highlight succession risks. Overall, the period shows active governance changes with mixed shareholder sentiment, presenting both opportunities and risks for investors.

48 high priority 48 total filings
· daily

US Merger & Acquisition SEC Filings — May 19, 2026

The May 19, 2026, US M&A filing stream reveals a market bifurcated between high-conviction, well-capitalized take-privates and a flurry of SPAC deadline extensions signaling execution risk. The most material event is the $3.1B take-private of Mister Car Wash by Leonard Green & Partners, a definitive bullish signal for the sector that validates asset values. Conversely, the SPAC landscape shows systemic strain: three separate SPACs (Plum, Bayview, EagleRock) disclosed deadline extensions, with Bayview's fourth amendment pushing its closing date over 2.5 years from the original agreement, indicating severe deal fatigue. A major capital markets event was EagleRock Land's $286.6M IPO, a rare positive signal for the Permian Basin asset class. Insider activity was notably absent across the stream, with only one director resignation (Valuence Merger Corp.) that was non-disputative, providing no conviction signals. Forward-looking data points to a catalyst-rich June, with Exascale Labs' COMPUTEX Taipei exhibition and Eton's IMPAVIDO launch in September creating specific alpha opportunities. The aggregate trend shows capital rotating away from SPAC structures toward direct listings and take-privates, with the Mister Car Wash deal demonstrating the premium available for quality assets in a rate-stabilizing environment.

10 high priority 10 total filings